United States

Northwestern Medicine enrolls first participant in brain tumor trial

Wednesday, August 28, 2013 02:47 PM

Northwestern Medicine recently joined a clinical trial to investigate if a vaccine made from a patient's own brain tumor is effective in slowing tumor progression and extending survival. The randomized, phase II trial will study how well giving the study vaccine with or without Avastin (bevacizumab) works in treating patients with recurrent glioblastoma multiforme (GBM).

More... »

Sangamo BioSciences to acquire Ceregene

Wednesday, August 28, 2013 12:35 PM

Sangamo BioSciences has agreed to acquire Ceregene, a privately held biotechnology company focused on developing adeno-associated virus (AAV) gene therapies. 

More... »

BARDA awards Novan $7.8 million contract

Tuesday, August 27, 2013 11:30 AM

The U.S. Department of Health and Human Services has entered into a contract with Novan, a clinical-stage drug development company focused on topical delivery of nitric oxide, to advance the development of a nitric oxide-based therapy as a topical treatment for thermal burns. 

More... »

Curemark, VTT Molecular Sciences Institute collaborate

Tuesday, August 27, 2013 09:30 AM

Curemark, a drug R&D company focused on neurological disorders, has entered into a collaborative research agreement with the VTT Molecular Sciences Institute (MSI), an independent, nonprofit research institute in Berkeley, Calif.

More... »

Cresset expands scientific team, relocates to Cambridge Cluster

Monday, August 26, 2013 12:19 PM

Cresset, a provider of chemistry software and services, has relocated near Cambridge Cluster, in Litlington, Cambridgeshire, which will serve as the company's global headquarters.

More... »

Pediatric auditory brainstem implant clinical trial awarded NIH grant

Friday, August 23, 2013 11:48 AM

House Research Institute (HRI) and Los Angeles Children’s Hospital have announced final approval of grant funding by the NIH National Institute on Deafness and Communications Disorders (NIDCD) for a five-year, FDA-approved clinical trial of the auditory brainstem implant (ABI) in children.

More... »

Boston Scientific completes enrollment in SuperNOVA clinical trial

Thursday, August 22, 2013 08:01 AM

Boston Scientifichas completed enrollment in the SuperNOVA trial, a global, single arm, prospective, multicenter trial evaluating the long-term (12 month) safety and effectiveness of the Innova Self-Expanding Stent System. This advanced stent system is designed for treating patients with a narrowing or blockage of the arteries above the knee, often associated with peripheral artery disease (PAD).

More... »

Neurodegeneration Consortium receives $5 million from Huffington Foundation

Wednesday, August 21, 2013 11:02 AM

The Huffington Foundation has committed $5 million to the Neurodegeneration Consortium (NDC), a multi-institutional collaboration to study and treat Alzheimer’s and other neurodegenerative diseases.

More... »

Pancreatic Cancer Action Network study suggests national trial coordination needed

Wednesday, August 21, 2013 10:49 AM

The Pancreatic Cancer Action Network conducted a research study on the landscape of pancreatic cancer clinical trials in the U.S. in order to better understand how to accelerate clinical progress against pancreatic cancer and achieve the organization's goal to double the survival rate by 2020. The findings were published in the Journal of Clinical Oncology.

More... »

RTI International to expand genomic research toolkit

Tuesday, August 20, 2013 09:21 AM

As part of a new award from the National Human Genome Research Institute, RTI International will expand the PhenX Toolkit, a web-based resource that supports collaborative genomics and biomedical research. Use of PhenX measures will help researchers understand the relationships between genetics, health, disease and environment.

More... »